New Key Statistics Module, Z-Score and F-Score
OTCPK:XVIPF Key Ratios
| Market Cap $ M | 1,521.41 |
| Enterprise Value $ M | 1,476.88 |
| P/E(ttm) | 128.10 |
| PE Ratio without NRI | 128.10 |
| Forward PE Ratio | 83.10 |
| Price/Book | 7.87 |
| Price/Sales | 22.36 |
| Price/Free Cash Flow | 223.60 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 66.00 |
| EPS (TTM) $ | 0.38 |
| Beneish M-Score | -2.27 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 343.90 |
| EV-to-EBIT | 116.32 |
| EV-to-EBITDA | 116.32 |
| PEG | -- |
| Shares Outstanding M | 31.50 |
| Net Margin (%) | 17.28 |
| Operating Margin % | 6.13 |
| Pre-tax Margin (%) | 18.49 |
| Quick Ratio | 3.27 |
| Current Ratio | 4.13 |
| ROA % (ttm) | 5.62 |
| ROE % (ttm) | 6.42 |
| ROIC % (ttm) | 2.38 |
| Dividend Yield % | -- |
| Altman Z-Score | 39.47 |
XVIPF Number of Guru Trades
XVIPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:XVIPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:XVIPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Xvivo Perfusion AB Insider Transactions
No Available Data
News about OTCPK:XVIPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers